Drosophila melanogaster as a model organism for Alzheimer's disease

Molecular Neurodegeneration

Volumn 8, Issue 1, 2013, Pages

  Prüßing, Katja ^a   Voigt, Aaron ^a   Schulz, Jörg B ^a,b,c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Julich Aachen Research Alliance JARA   (Germany)

^c EURON European Graduate School of Neuroscience   (Germany)

Author keywords

Alzheimer's disease; Amyloid ; Drosophila melanogaster; Tau

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BETA SECRETASE; CYTOSKELETON PROTEIN; ERLOTINIB; GEFITINIB; PHOSPHATASE; PHOSPHOTRANSFERASE; PRESENILIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMNESIA; DISEASE MODEL; DROSOPHILA MELANOGASTER; FRUIT FLY MODEL; HUMAN; IN VIVO STUDY; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; ORTHOLOGY; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; SHORT TERM MEMORY;

DROSOPHILA MELANOGASTER; VERTEBRATA;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS; TAU PROTEINS;

EID: 84887869663     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-8-35     Document Type: Review

References (86)

1. Global prevalence of dementia: a Delphi consensus study. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, et al. Lancet 2005 366 2112 2117 16360788 (Pubitemid 41797645)
2. An overview of APP processing enzymes and products. Chow VW, Mattson MP, Wong PC, Gleichmann M, Neuromolecular Med 2010 12 1 12 10.1007/s12017-009-8104-z 20232515
3. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C, J Biol Chem 1992 267 546 554 1730616
4. Tau in Alzheimer disease and related tauopathies. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I, Curr Alzheimer Res 2010 7 656 664 10.2174/ 156720510793611592 20678074
5. Alzheimer's disease: the amyloid cascade hypothesis. Hardy JA, Higgins GA, Science 1992 256 184 185 10.1126/science.1566067 1566067
6. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, Wiltfang J, Esselmann H, de Strooper B, J Neurochem 2006 96 732 742 10.1111/j.1471-4159.2005.03578.x 16405513
7. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, et al. Nat Neurosci 2001 4 887 893 10.1038/nn0901-887 11528419 (Pubitemid 32801591)
8. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, Eckman C, Golde TE, Younkin SG, Science 1994 264 1336 1340 10.1126/science.8191290 8191290
9. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B, Proc Natl Acad Sci USA 1998 95 7737 7741 10.1073/pnas.95.13.7737 9636220 (Pubitemid 28293323)
10. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, et al. Nature 1998 393 702 705 10.1038/31508 9641683 (Pubitemid 28289662)
11. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM, J Neurochem 2007 102 1053 1063 10.1111/j.1471-4159.2007.04607.x 17472708 (Pubitemid 47174220)
12. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L, Science 2007 316 750 754 10.1126/science.1141736 17478722 (Pubitemid 46717684)
13. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, et al. Cell 2010 142 387 397 10.1016/j.cell.2010.06.036 20655099
14. Protein folding diseases and neurodegeneration: lessons learned from yeast. Winderickx J, Delay C, de Vos A, Klinger H, Pellens K, Vanhelmont T, van Leuven F, Zabrocki P, Biochim Biophys Acta 2008 1783 1381 1395 10.1016/j.bbamcr.2008.01.020 18298958
15. What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases? Teschendorf D, Link CD, Mol Neurodegener 2009 4 38 10.1186/1750-1326-4-38 19785750
16. Tau filament formation in transgenic mice expressing P301L tau. Gotz J, Chen F, Barmettler R, Nitsch RM, J Biol Chem 2001 276 529 534 11013246 (Pubitemid 32050347)
17. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G, Science 1996 274 99 102 10.1126/science.274.5284.99 8810256 (Pubitemid 26332733)
18. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, et al. Proc Natl Acad Sci USA 1997 94 13287 13292 10.1073/pnas.94.24.13287 9371838 (Pubitemid 27518514)
19. Invertebrate models of Alzheimer's disease. Mhatre SD, Paddock BE, Saunders AJ, Marenda DR, J Alzheimers Dis 2013 33 3 16 22886023
20. Sex Limited Inheritance in Drosophila. Morgan TH, Science 1910 32 120 122 10.1126/science.32.812.120 17759620
21. The genome sequence of Drosophila melanogaster. Adams MD, Celniker SE, Holt RA, Evans CA, Gocayne JD, Amanatides PG, Scherer SE, Li PW, Hoskins RA, Galle RF, et al. Science 2000 287 2185 2195 10.1126/science.287.5461.2185 10731132 (Pubitemid 30177013)
22. Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery. Nichols CD, Pharmacol Ther 2006 112 677 700 10.1016/j.pharmthera.2006.05.012 16935347 (Pubitemid 44573493)
23. Thirty years of olfactory learning and memory research in Drosophila melanogaster. McGuire SE, Deshazer M, Davis RL, Prog Neurobiol 2005 76 328 347 10.1016/j.pneurobio.2005.09.003 16266778 (Pubitemid 41612176)
24. Greenspan RJ, Fly Pushing: The Theory and Practice of Drosophila Genetics New Jersey: Cold Spring Harbour Laboratory Press 2004
25. Drosophila as a screening tool to study human neurodegenerative diseases. Lenz S, Karsten P, Schulz JB, Voigt A, J Neurochem 2013 127 453 60 10.1111/jnc.12446 24028575
26. Drosophila as a model to study age-related neurodegenerative disorders: Alzheimer's disease. Bonner JM, Boulianne GL, Exp Gerontol 2011 46 335 339 10.1016/j.exger.2010.08.004 20719244
27. Insights from Drosophila models of Alzheimer's disease. Cowan CM, Shepherd D, Mudher A, Biochem Soc Trans 2010 38 988 992 10.1042/BST0380988 20658990
28. Comparative genomics of the eukaryotes. Rubin GM, Yandell MD, Wortman JR, Gabor Miklos GL, Nelson CR, Hariharan IK, Fortini ME, Li PW, Apweiler R, Fleischmann W, et al. Science 2000 287 2204 2215 10.1126/science.287.5461.2204 10731134 (Pubitemid 30177015)
29. A survey of human disease gene counterparts in the Drosophila genome. Fortini ME, Skupski MP, Boguski MS, Hariharan IK, J Cell Biol 2000 150 23 30 10.1083/jcb.150.2.F23 10908582
30. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Luo L, Tully T, White K, Neuron 1992 9 595 605 10.1016/0896-6273(92)90024-8 1389179
31. Functional reconstitution of gamma-secretase through coordinated expression of presenilin, nicastrin, Aph-1, and Pen-2. Periz G, Fortini ME, J Neurosci Res 2004 77 309 322 10.1002/jnr.20203 15248287 (Pubitemid 38970975)
32. Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function. Carmine-Simmen K, Proctor T, Tschape J, Poeck B, Triphan T, Strauss R, Kretzschmar D, Neurobiol Dis 2009 33 274 281 10.1016/j.nbd.2008.10.014 19049874
33. Overexpression of human amyloid precursor protein in Drosophila. Yagi Y, Tomita S, Nakamura M, Suzuki T, Mol Cell Biol Res Commun 2000 4 43 49 10.1006/mcbr.2000.0248 11152627
34. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Crowther DC, Kinghorn KJ, Miranda E, Page R, Curry JA, Duthie FA, Gubb DC, Lomas DA, Neuroscience 2005 132 123 135 10.1016/j.neuroscience.2004.12.025 15780472 (Pubitemid 40380720)
35. A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster. Finelli A, Kelkar A, Song HJ, Yang H, Konsolaki M, Mol Cell Neurosci 2004 26 365 375 10.1016/j.mcn.2004.03.001 15234342 (Pubitemid 38968431)
36. Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila. Greeve I, Kretzschmar D, Tschape JA, Beyn A, Brellinger C, Schweizer M, Nitsch RM, Reifegerste R, J Neurosci 2004 24 3899 3906 10.1523/JNEUROSCI.0283-04.2004 15102905 (Pubitemid 38544216)
37. Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. Iijima K, Chiang HC, Hearn SA, Hakker I, Gatt A, Shenton C, Granger L, Leung A, Iijima-Ando K, Zhong Y, PLoS One 2008 3 1703 10.1371/journal.pone.0001703 18301778 (Pubitemid 351891285)
38. Apoptotic activities of wild-type and Alzheimer's disease-related mutant presenilins in Drosophila melanogaster. Ye Y, Fortini ME, J Cell Biol 1999 146 1351 1364 10.1083/jcb.146.6.1351 10491396 (Pubitemid 29477700)
39. Ectopic gene expression in Drosophila using GAL4 system. Phelps CB, Brand AH, Methods 1998 14 367 379 10.1006/meth.1998.0592 9608508 (Pubitemid 28404254)
40. Transcriptional regulation in the yeast GAL gene family: a complex genetic network. Lohr D, Venkov P, Zlatanova J, FASEB J 1995 9 777 787 7601342
41. How eukaryotic transcriptional activators work. Ptashne M, Nature 1988 335 683 689 10.1038/335683a0 3050531
42. Bloomington Stock Center [ http://flystocks.bio.indiana.edu/Browse/in/ misexpression-top.php ]
43. The glass gene encodes a zinc-finger protein required by Drosophila photoreceptor cells. Moses K, Ellis MC, Rubin GM, Nature 1989 340 531 536 10.1038/340531a0 2770860 (Pubitemid 19201693)
44. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Brand AH, Perrimon N, Development 1993 118 401 415 8223268 (Pubitemid 23214028)
45. A modular misexpression screen in Drosophila detecting tissue-specific phenotypes. Rorth P, Proc Natl Acad Sci USA 1996 93 12418 12422 10.1073/pnas.93.22.12418 8901596 (Pubitemid 26367158)
46. Szeged Drosophila Stock Center [ http://expbio.bio.u-szeged.hu/fly/ modules.php?name?=?Other-Stocks&op?=?OtherStocksList&stock-gr?=?4 ]
47. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, Fellner M, Gasser B, Kinsey K, Oppel S, Scheiblauer S, et al. Nature 2007 448 151 156 10.1038/nature05954 17625558 (Pubitemid 47067374)
48. Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila. Zhao XL, Wang WA, Tan JX, Huang JK, Zhang X, Zhang BZ, Wang YH, YangCheng HY, Zhu HL, Sun XJ, Huang FD, J Neurosci: the official journal of the Society for Neuroscience 2010 30 1512 1522 10.1523/JNEUROSCI. 3699-09.2010
49. Age-dependent alterations in the presynaptic active zone in a Drosophila model of Alzheimer's disease. Huang JK, Ma PL, Ji SY, Zhao XL, Tan JX, Sun XJ, Huang FD, Neurobiol Dis 2013 51 161 167 23149068
50. Amyloid-beta depresses excitatory cholinergic synaptic transmission in Drosophila. Fang L, Duan J, Ran D, Fan Z, Yan Y, Huang N, Gu H, Zhu Y, Neurosci Bull 2012 28 585 594 10.1007/s12264-012-1267-x 23054636
51. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y, Proc Natl Acad Sci USA 2004 101 6623 6628 10.1073/pnas.0400895101 15069204 (Pubitemid 38586024)
52. Epidermal growth factor receptor is a preferred target for treating amyloid-beta-induced memory loss. Wang L, Chiang HC, Wu W, Liang B, Xie Z, Yao X, Ma W, Du S, Zhong Y, Proc Natl Acad Sci USA 2012 109 16743 16748 10.1073/pnas.1208011109 23019586
53. Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice. Martinez-Coria H, Green KN, Billings LM, Kitazawa M, Albrecht M, Rammes G, Parsons CG, Gupta S, Banerjee P, LaFerla FM, Am J Pathol 2010 176 870 880 10.2353/ajpath.2010.090452 20042680
54. Copper, iron and zinc in Alzheimer's disease senile plaques. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR, J Neurol Sci 1998 158 47 52 10.1016/S0022-510X(98)00092-6 9667777 (Pubitemid 28277534)
55. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA, Tanzi RE, Bush AI, J Biol Chem 1998 273 12817 12826 10.1074/jbc.273.21.12817 9582309 (Pubitemid 28246837)
56. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. Cherny RA, Legg JT, McLean CA, Fairlie DP, Huang X, Atwood CS, Beyreuther K, Tanzi RE, Masters CL, Bush AI, J Biol Chem 1999 274 23223 23228 10.1074/jbc.274.33.23223 10438495 (Pubitemid 29388072)
57. Toxicity of Alzheimer's disease-associated Abeta peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability. Hua H, Munter L, Harmeier A, Georgiev O, Multhaup G, Schaffner W, Biol Chem 2011 392 919 926 21801085
58. Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Abeta42-induced Alzheimer's disease-like symptoms. Lang M, Fan Q, Wang L, Zheng Y, Xiao G, Wang X, Wang W, Zhong Y, Zhou B, Neurobiol Aging 2013 34 2604 2612 10.1016/j.neurobiolaging. 2013.05.029 23827522
59. Genetic inhibition of solute-linked carrier 39 family transporter 1 ameliorates abeta pathology in a Drosophila model of Alzheimer's disease. Lang M, Wang L, Fan Q, Xiao G, Wang X, Zhong Y, Zhou B, PLoS Genet 2012 8 1002683 10.1371/journal.pgen.1002683 22570624
60. Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. Liu B, Moloney A, Meehan S, Morris K, Thomas SE, Serpell LC, Hider R, Marciniak SJ, Lomas DA, Crowther DC, J Biol Chem 2011 286 4248 4256 10.1074/jbc.M110.158980 21147772
61. Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Rival T, Page RM, Chandraratna DS, Sendall TJ, Ryder E, Liu B, Lewis H, Rosahl T, Hider R, Camargo LM, et al. Eur J Neurosci 2009 29 1335 1347 10.1111/j.1460-9568.2009. 06701.x 19519625
62. Aluminum induces neurodegeneration and its toxicity arises from increased iron accumulation and reactive oxygen species (ROS) production. Wu Z, Du Y, Xue H, Wu Y, Zhou B, Neurobiol Aging 2012 33 199 e191-112
63. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Feany MB, Dickson DW, Ann Neurol 1996 40 139 148 10.1002/ana.410400204 8773594 (Pubitemid 26274548)
64. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB, Science 2001 293 711 714 10.1126/science.1062382 11408621 (Pubitemid 32728676)
65. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K, Proc Natl Acad Sci USA 2001 98 6923 6928 10.1073/pnas.121119298 11381127 (Pubitemid 32538318)
66. Expression of Alzheimer-like pathological human Tau induces a behavioral motor and olfactory learning deficit in Drosophila melanogaster. Beharry C, Alaniz ME, Alonso Adel C, J Alzheimers Dis 2013 37 539 550 23948901
67. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Chatterjee S, Sang TK, Lawless GM, Jackson GR, Hum Mol Genet 2009 18 164 177 18930955
68. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH, Neuron 2002 34 509 519 10.1016/S0896-6273(02)00706-7 12062036 (Pubitemid 34628749)
69. Genetic modifiers of tauopathy in Drosophila. Shulman JM, Feany MB, Genetics 2003 165 1233 1242 14668378 (Pubitemid 38020245)
70. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila. Blard O, Feuillette S, Bou J, Chaumette B, Frebourg T, Campion D, Lecourtois M, Hum Mol Genet 2007 16 555 566 10.1093/hmg/ddm011 17309878 (Pubitemid 46522618)
71. Functional genomics screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Ambegaokar SS, Jackson GR, Hum Mol Genet 2011 20 4947 4977 10.1093/hmg/ddr432 21949350
72. Identification of novel genes that modify phenotypes induced by Alzheimer's beta-amyloid overexpression in Drosophila. Cao W, Song HJ, Gangi T, Kelkar A, Antani I, Garza D, Konsolaki M, Genetics 2008 178 1457 1471 10.1534/genetics.107.078394 18245849
73. A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration. Iijima-Ando K, Zhao L, Gatt A, Shenton C, Iijima K, Hum Mol Genet 2010 19 1930 1938 10.1093/hmg/ddq068 20159774
74. S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. Steinhilb ML, Dias-Santagata D, Mulkearns EE, Shulman JM, Biernat J, Mandelkow EM, Feany MB, J Neurosci Res 2007 85 1271 1278 10.1002/jnr.21232 17335084 (Pubitemid 46724370)
75. Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Steinhilb ML, Dias-Santagata D, Fulga TA, Felch DL, Feany MB, Mol Biol Cell 2007 18 5060 5068 10.1091/mbc.E07-04-0327 17928404 (Pubitemid 350246705)
76. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Folwell J, Cowan CM, Ubhi KK, Shiabh H, Newman TA, Shepherd D, Mudher A, Exp Neurol 2010 223 401 409 10.1016/j.expneurol.2009.09.014 19782075
77. Transsynaptic coordination of synaptic growth, function, and stability by the L1-Type CAM Neuroglian. Enneking EM, Kudumala SR, Moreno E, Stephan R, Boerner J, Godenschwege TA, Pielage J, PLoS Biol 2013 11 1001537 10.1371/journal.pbio.1001537 23610557
78. A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma. Read RD, Fenton TR, Gomez GG, Wykosky J, Vandenberg SR, Babic I, Iwanami A, Yang H, Cavenee WK, Mischel PS, et al. PLoS Genet 2013 9 1003253 10.1371/journal.pgen.1003253 23459592
79. A targeted in vivo RNAi screen reveals deubiquitinases as new regulators of Notch signaling. Zhang J, Liu M, Su Y, Du J, Zhu AJ, G3 (Bethesda) 2012 2 1563 1575 2012 23275879
80. A novel inhibitor of amyloid beta (Abeta) peptide aggregation: from high throughput screening to efficacy in an animal model of Alzheimer disease. McKoy AF, Chen J, Schupbach T, Hecht MH, J Biol Chem 2012 287 38992 39000 10.1074/jbc.M112.348037 22992731
81. Large-scale screen for modifiers of ataxin-3-derived polyglutamine- induced toxicity in Drosophila. Voßfeldt H, Butzlaff M, Prüßing K, Ni Charthaigh RA, Karsten P, Lankes A, Hamm S, Simons M, Adryan B, Schulz JB, Voigt A, PLoS One 2012 7 47452 10.1371/journal.pone.0047452 23139745
82. Genome-wide screen for modifiers of Ab42-induced neurodegeneration in Drosophila. Wednesday 31 August 2011. Prüßing K, Voigt A, Schulz JB, J Neurochem 2011 118 165 244
83. The fox and the rabbits-environmental variables and population genetics (1) replication problems in association studies and the untapped power of GWAS (2) vitamin A deficiency, herpes simplex reactivation and other causes of Alzheimer's disease. Carter CJ, ISRN Neurol 2011 2011 394678 22389816
84. Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting. Rajendran L, Schneider A, Schlechtingen G, Weidlich S, Ries J, Braxmeier T, Schwille P, Schulz JB, Schroeder C, Simons M, et al. Science 2008 320 520 523 10.1126/science.1156609 18436784 (Pubitemid 351590663)
85. Progress toward a practical BACE-1 inhibitor. Hills ID, Vacca JP, Curr Opin Drug Discov Devel 2007 10 383 391 17659479 (Pubitemid 47093121)
86. Design of substrate-based inhibitors of human beta-secretase. Tung JS, Davis DL, Anderson JP, Walker DE, Mamo S, Jewett N, Hom RK, Sinha S, Thorsett ED, John V, J Med Chem 2002 45 259 262 10.1021/jm0155695 11784130 (Pubitemid 34073445)